Working together with IBT
Innovative BioTherapies, Inc. (IBT), is a for profit company founded in 2003, by Dr. H. David Humes, Professor of Medicine at the University of Michigan, to facilitate the commercialization of technology developed in his academic laboratory. IBT’s research and development program is primarily supported by a number of federal grants and contracts, which focus on developing bioartificial organ based devices utilizing adult progenitor cells, biomaterials and MEMs technology.